Symptom Clusters in Children With Leukemia

The purpose of this study is to examine the phenotypic and genotypic characteristics and their associations with symptom clusters experienced during treatment for childhood leukemia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Childhood Leukemia

Age range

3 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Arizona, Tucson, Arizona, United States

About this study

A repeated measures research design will evaluate phenotypic and genotypic treatment-related symptom associations experienced by children and adolescents 3-17 years of age with a diagnosis of leukemia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Phenotypic and genotypic treatment-related symptom associations will be evaluated in children and adolescents 3-18 years of age with a diagnosis of leukemia.

Exclusion criteria

Children without a definite diagnosis of leukemia will be excluded.
Children must be able to understand and answer the questions on the questionnaires.
Children with have a cognitive impairment (e.g. Down syndrome) will not be able to complete the questionnaires and will not be eligible for the study.

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

Phenotypic and Genotypic Associations With Symptom Clusters During Childhood Leukemia Treatment

Important dates

Study start: 2012
Primary completion: 2018
Study completion: 2018
First posted: Oct 17, 2012
Registry last updated: Nov 6, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Enrolling by Invitation